SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-22-015513
Filing Date
2022-04-26
Accepted
2022-04-26 07:33:34
Documents
6
Period of Report
2022-06-14

Document Format Files

Seq Description Document Type Size
1 DEF 14A aadi-def14a_20220614.htm DEF 14A 903476
2 GRAPHIC ggkh1kxe03zj000005.jpg GRAPHIC 57919
3 GRAPHIC ggkh1kxe03zj000002.jpg GRAPHIC 2078
4 GRAPHIC ggkh1kxe03zj000004.jpg GRAPHIC 54786
5 GRAPHIC ggkh1kxe03zj000003.jpg GRAPHIC 3211
6 GRAPHIC ggkh1kxe03zj000001.jpg GRAPHIC 2078
  Complete submission text file 0001564590-22-015513.txt   1070842
Mailing Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272
Business Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272 424-473-8055
Aadi Bioscience, Inc. (Filer) CIK: 0001422142 (see all company filings)

IRS No.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38560 | Film No.: 22851785
SIC: 2834 Pharmaceutical Preparations